Checking Up on the King of Cancers
Abstract
Pancreatic cancer is known as the "king of cancers" due to its aggressive progression and poor prognosis. Wang, Wang, Zhang, and colleagues develop a promising liquid biopsy approach that uses features derived from a single run of low-pass whole-genome cell-free DNA sequencing to predict pancreatic cancer years before diagnosis in a large asymptomatic high-risk cohort, markedly outperforming existing biomarkers and projecting survival gains. See related article by Wang et al., p. 66.
Fields of Study & Subjects
Cancer Genomics and Diagnostics
Pancreatic and Hepatic Oncology Research
Global Cancer Incidence and Screening
Publication details
- Journal / source
- Cancer Discovery
- Volume
- 16
- Issue
- 1
- Pages
- 10–12
- Publication date
- 12 January 2026
- Language
- EN